BenzingaDoubao · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 20:27:07·⟳ 抓取 20:27:16 +9s·⚡ 决策 10-21 20:28:28 +1m12s·5.9 天前
Benzinga 前瞻：Lam Research 今日盘后发财报，罗列分析师目标价，无实际业绩
本文是财报发布前数小时的媒体前瞻汇总，一致预期、目标价（最早可追溯至7月30日）、股息调整均为市场已知旧信息，无任何实际业绩或指引增量；近72小时内 Seeking Alpha 同类前瞻已研判为不做，本条未带来会改变结论的新事实。盘前对一笔当晚才揭晓的二元财报事件下注，多空均无信息 edge。
📄 原文Benzinga↗ 原文
Lam Research Corporation (NASDAQ:LRCX) will release its first-quarter earnings report after the closing bell on Wednesd…
不做 Lam Research（LRCX.US）
财报前数小时的媒体前瞻，无实际业绩或指引增量（一致预期与目标价均为旧信息），盘前下注是对今晚盘后二元财报事件的赌博；年内大涨+乐观预期或已定价，多空均无信息 edge。待 10-21 盘后实际 EPS/营收/指引落地后再研判，并届时评估对 AMAT、KLAC 及 A股半导体设备链的外溢。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Benzinga 盘前瞻稿仅复述 LRCX 一致预期（EPS 2.18 美元、营收 81.3 亿美元）与多位分析师数周至数月前的旧目标价，财报今晚盘后才公布；无增量事实、无 edge，不做，待实际数据与指引落地后再研判。
🔎 新鲜度:最早出现 2026-10-21 · 扩散 high · price-in 风险 high ↗
主要风险
- 今晚盘后实际财报与指引为二元事件，无论超预期或不及预期均可能造成次日大幅跳空，盘前任何方向仓位都承担无对冲的事件赌博风险
- 股价年内已大幅上涨、乐观预期（近三个月25个EPS预估上调）或已部分定价，beat 也可能 sell-the-news
反向证据
- 做多前查反向 · 来源 web · 日期 2026-10-20 · 影响 weakens
近三个月25个EPS预估上调、0下调，多家大行维持买入但部分已下调目标价（Wells Fargo 450→350），乐观预期与目标价分歧并存；年内+53%涨幅意味着即便 beat 也有 sell-the-news 风险，盘前做多无 edge
检索:LRCX earnings preview analyst price target cuts China WFE guidance risk
先例如何影响了这次决策
对本次决策的影响:确认不做：在缺少实际业绩这一锚点的情况下，不据旧目标价或一致预期设定任何止盈止损
方向:财报前无增量的媒体前瞻不构成可定价事件，无可对照的事件反应；真正应测的先例是 LRCX 及同业实际财报后的跳空反应，须待今晚数据后另行研究
涨幅量级:无高相似对齐先例，不用任何前瞻类稿件校准幅度
形态:不适用
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 1,648 ms
{"result": "search_processed_events:agent query=`lam research lrcx first quarter earnings preview analyst price target | lrcx q1 2027 earnings october 21 consensus eps revenue | 泛林集团 一季度财报 分析师目标价`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 71.9/72 小时、22714 条本臂决策(完整)，返回 1 条候选。\n• 10-20 17:51 UTC(北京 10-21 01:51) [bm25:
原文全文
展开原文 · 1,946 字
Lam Research Corporation (NASDAQ:LRCX) will release its first-quarter earnings report after the closing bell on Wednesday, Oct. 21.
Analysts expect the Fremont, California-based company to report quarterly earnings of $2.18 per share, up from $1.26 per share in the year-ago period. The consensus estimate for LRCX’s quarterly revenue is $8.13 billion. It reported $5.32 billion last year, according to Benzinga Pro.
On Aug. 27, Lam Research increased its quarterly dividend from 26 cents to 33 cents per share.
Lam Research shares dropped 3.2% to close at $263.45 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Morgan Stanley analyst Shane Brett maintained an Overweight rating and raised the price target from $367 to $385 on Oct. 5, 2026. This analyst has an accuracy rate of 70%.
- B. Riley Securities analyst Craig Ellis maintained a Buy rating and boosted the price target from $350 to $390 on Oct. 1, 2026. This analyst has an accuracy rate of 83%.
- UBS analyst Timothy Arcuri maintained a Buy rating and cut the price target from $435 to $425 on Sept. 1, 2026. This analyst has an accuracy rate of 87%.
- Mizuho analyst Vijay Rakesh maintained an Outperform rating and slashed the price target from $370 to $365 on Aug. 25, 2026. This analyst has an accuracy rate of 83%.
- Wells Fargo analyst Joe Quatrochi maintained an Overweight rating and cut the price target from $450 to $350 on July 30, 2026. This analyst has an accuracy rate of 71%.
Considering buying LRCX stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Analysts expect the Fremont, California-based company to report quarterly earnings of $2.18 per share, up from $1.26 per share in the year-ago period. The consensus estimate for LRCX’s quarterly revenue is $8.13 billion. It reported $5.32 billion last year, according to Benzinga Pro.
On Aug. 27, Lam Research increased its quarterly dividend from 26 cents to 33 cents per share.
Lam Research shares dropped 3.2% to close at $263.45 on Tuesday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.
- Morgan Stanley analyst Shane Brett maintained an Overweight rating and raised the price target from $367 to $385 on Oct. 5, 2026. This analyst has an accuracy rate of 70%.
- B. Riley Securities analyst Craig Ellis maintained a Buy rating and boosted the price target from $350 to $390 on Oct. 1, 2026. This analyst has an accuracy rate of 83%.
- UBS analyst Timothy Arcuri maintained a Buy rating and cut the price target from $435 to $425 on Sept. 1, 2026. This analyst has an accuracy rate of 87%.
- Mizuho analyst Vijay Rakesh maintained an Outperform rating and slashed the price target from $370 to $365 on Aug. 25, 2026. This analyst has an accuracy rate of 83%.
- Wells Fargo analyst Joe Quatrochi maintained an Overweight rating and cut the price target from $450 to $350 on July 30, 2026. This analyst has an accuracy rate of 71%.
Considering buying LRCX stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
b9f40db667· 2026-10-21 20:28 · doubao / doubao-seed-evolving-latest-version · 策略包658c0c1e2ba5当前